AI system trialed in Belgian breast clinics to tailor cancer therapy

An AI system is being tested in Belgian breast clinics to predict chemotherapy response, lymph node involvement, and tumor size at treatment onset, aiming to personalize cancer treatment. The technology's clinical validation and impact on treatment decisions remain unproven at scale. This marks a notable step in applying AI to oncology, potentially improving treatment precision and outcomes.